Skip to main navigation
Skip to search
Skip to main content
Discover Research at University College Cork Home
Search content at Discover Research at University College Cork
Home
Profiles
Research units
Research output
Activities
Prizes
Datasets
Impacts
Courses
Press/Media
Optimizing HER2-Directed Therapy in Early-Stage Breast Cancer
Evanthia T. Roussos Torres
,
Roisin M. Connolly
Johns Hopkins University
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Optimizing HER2-Directed Therapy in Early-Stage Breast Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Breast Cancer
100%
Disease Free Survival
50%
Chemotherapy
50%
Diseases
25%
Patient Population
25%
Biological Marker
25%
Overall Survival
25%
Pertuzumab
25%
Trastuzumab
25%
Recurrence Risk
25%
Neratinib
25%
Treatment Option
25%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Disease Free Survival
50%
Chemotherapy Regimen
50%
Diseases
25%
Biological Marker
25%
Recurrence Risk
25%
Trastuzumab
25%
Pertuzumab
25%
Overall Survival
25%
Neratinib
25%
Immunology and Microbiology
Disease Free Survival
100%
Overall Survival
50%
Pertuzumab
50%
Trastuzumab
50%